West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 91/100

West Pharmaceutical Services Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 12:30AM GMT
Tejas Rajeev Savant
JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. Thanks for staying until the end on Wednesday. It's my -- my name is Tejas Savant, and I work with Tycho on the life sciences team at JPMorgan. It's my pleasure this afternoon to introduce Eric Green, CEO of West Pharmaceuticals. At the end of Eric's presentation, there will be a management breakout in the Borgia Room, which is right outside.

With that, I'd like to hand it over to Eric.

Eric M. Green
West Pharmaceutical Services, Inc. - CEO, President & Director

Great. Tejas, thank you. And thank you for the invitation to participate this year at the JPMorgan Healthcare Conference. Great series of conversations all day today.

Before I get started, I just want to remind you about our safe harbor statement that's here posted on this PowerPoint presentation. But also, you can find our safe harbor statement in our website at westpharma.com.

Let me tell you a little bit about West and the story of West. We are -- our focus is around

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot